Heteroresistance to Fluconazole and Voriconazole in Cryptococcus neoformans
- 1 August 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (8) , 1856-1861
- https://doi.org/10.1128/aac.43.8.1856
Abstract
Cryptococcus neoformans isolates that exhibited unusual patterns of resistance to fluconazole and voriconazole were isolated from seven isolates from two different geographical regions: one isolate from an Israeli non-AIDS patient and six serial isolates from an Italian AIDS patient who had suffered six recurrent episodes of cryptococcal meningitis. Each isolate produced cultures with heterogeneous compositions in which most of the cells were susceptible, but cells highly resistant to fluconazole (MICs, ≥64 μg/ml) were recovered at a variable frequency (7 × 10−3 to 4.6 × 10−2). Evidence showed that this type of resistance is innate and is unrelated to drug exposure since the Israeli patient had never been treated with azoles or any other antimycotic agents. Analysis of clonal subpopulations of these two strains showed that they exhibited heterogeneous patterns of resistance. The number of subpopulations which grew on fluconazole or voriconazole agar declined progressively with increasing azole concentration without a sharp cutoff point. For the Italian serial isolates, the number of clonal populations resistant to fluconazole (64 μg/ml) and voriconazole (1 μg/ml) increased steadily, yielding the highest number for the isolate from the last episode. Attempts to purify a sensitive subpopulation failed, but clones highly resistant to fluconazole (100 μg/ml) and moderately resistant to voriconazole (1 μg/ml) always produced a homogeneous population of resistant cells. Upon maintenance on drug-free medium, however, the majority of the homogeneously resistant cells of these subclones lost their resistance and returned to the stable initial heteroresistant phenotype. The pattern of heteroresistance was not affected by the pH or osmolarity of the medium but was influenced by temperature. The resistance appeared to be suppressed at 35°C and was completely abolished at 40°C. Although heterogeneity in azole resistance among subpopulations of single isolates has been reported for Candida species, the transient changes in expression of resistance under different growth conditions reported here have not been observed in fungal pathogens.Keywords
This publication has 46 references indexed in Scilit:
- Possible Development of Resistance to Fluconazole During Suppressive Therapy for AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Impact ofsarandagron methicillin resistance inStaphylococcus aureusFEMS Microbiology Letters, 1996
- Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility TestingClinical Infectious Diseases, 1996
- Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent MeningitisClinical Infectious Diseases, 1994
- Gastrointestinal Visceral Motor Complications of Dermatomal Herpes Zoster: Report of Two Cases and ReviewClinical Infectious Diseases, 1993
- Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal MeningitisThe Journal of Infectious Diseases, 1993
- Persistence of initial infection in recurrent Cryptococcus neoformans meningitisThe Lancet, 1993
- Resistance heterogeneity in methicillin-resistantStaphylococcus aureusFEMS Microbiology Letters, 1984
- Resistance heterogeneity in methicillin-resistant Staphylococcus aureusFEMS Microbiology Letters, 1984
- Methicillin-Resistant Staphylococci: Genetics of the Minority PopulationJournal of General Microbiology, 1966